The Influence of Sport and Structured Exercise in Prostate Cancer Management: Recommended Modalities and Narrative Review
DOI:
https://doi.org/10.12775/QS.2026.65.74208Keywords
Prostate cancer, Physical activity in treatment, Radical prostatectomy, Pelvic floor muscles training, Androgen deprivation therapyAbstract
Prostate cancer is one of the most common malignancies among men, with a steadily increasing global incidence. Over recent decades, major advances in imaging techniques and therapeutic strategies have significantly improved diagnostic accuracy and survival outcomes. Nevertheless, treatment-related adverse effects remain a substantial clinical challenge and frequently impair patients’ quality of life. This review summarizes current diagnostic approaches and treatment modalities for prostate cancer, with a particular emphasis on the influence of sport and structured exercise recommendations as supportive interventions. Exercise has been shown to improve physical function, reduce fatigue, and enhance quality of life during and after treatment.
In the setting of radical prostatectomy, both preoperative and postoperative exercise interventions, particularly pelvic floor muscle training, accelerate functional recovery and reduce urinary incontinence. In patients undergoing androgen deprivation therapy, physical activity, especially resistance training, effectively counteracts treatment-related adverse effects, including loss of muscle mass, increased adiposity, fatigue, and psychological disturbances. Although current evidence regarding the association between physical activity and reduced prostate cancer risk remains inconclusive, emerging data suggest that exercise may positively influence disease progression and survival outcomes. Physical activity should therefore be considered an integral component of comprehensive prostate cancer care. Further studies are required to establish standardized and evidence-based exercise guidelines for this patient population.
References
1. Raychaudhuri R, Lin DW, Montgomery RB. Prostate cancer: a review. Oncology JAMA. 2025;333(16):1433-1446. doi:10.1001/jama.2025.0228.
2. Falagario UG, Knipper S, Pellegrino F, Martini A, Akre O, Egevad L, et al. Prostate cancer-specific and all-cause mortality after robot-assisted radical prostatectomy: 20 years' report from the European Association of Urology Robotic Urology Section Scientific Working Group. Eur Urol Oncol. 2024;7(4):705-712. doi:10.1016/j.euo.2023.08.005.
3. Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022;27(17):5730. doi:10.3390/molecules27175730.
4. Bourke L, Smith D, Steed L, Hooper R, Carter A, Catto J, et al. Exercise for men with prostate cancer: a systematic review and meta-analysis. Eur Urol. 2016;69(4):693-703. doi:10.1016/j.eururo.2015.10.047.
5. Bourke L, Boorjian SA, Briganti A, Klotz L, Mucci L, Resnick MJ, et al. Survivorship and improving quality of life in men with prostate cancer. Eur Urol. 2015;68(3):374-383. doi:10.1016/j.eururo.2015.04.023.
6. Chan K, Ghani DAM, Teoh J, Brodie A, Gan C, Foley C, et al. Optimising prostate biopsies and imaging for the future-a review. Urol Oncol. 2024;42(12):421-428. doi:10.1016/j.urolonc.2024.08.019.
7. Albers P, Kinnaird A. Advanced imaging for localized prostate cancer. Cancers (Basel). 2024;16(20):3490. doi:10.3390/cancers16203490.
8. Alshamrani AFA. Diagnostic accuracy of molecular imaging techniques for detecting prostate cancer: a systematic review. Diagnostics (Basel). 2024;14(13):1315. doi:10.3390/diagnostics14131315.
9. Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024;86(2):148-163. doi:10.1016/j.eururo.2024.03.027.
10. Smani S, DuBois J, Ajjawi I, Sohoni N, Choksi AU, Lokeshwar SD, et al. Advances in current treatment paradigms for metastatic hormone-sensitive prostate cancer. J Clin Med. 2025;14(8):2565. doi:10.3390/jcm14082565.
11. Turco F, Gillessen S, Herrmann K, Paone G, Omlin A. Treatment landscape of prostate cancer in the era of PSMA radiopharmaceutical therapy. J Nucl Med. 2025;66(5):665-672. doi:10.2967/jnumed.124.267730.
12. Hamblen AJ, Bray JW, Hingorani M, Saxton JM. Physical activity and dietary considerations for prostate cancer patients: future research directions. Proc Nutr Soc. 2023;82(3):298-304. doi:10.1017/S0029665123000046.
13. McTiernan A, Friedenreich CM, Katzmarzyk PT, Powell KE, Macko R, Buchner D, et al. Physical activity in cancer prevention and survival: a systematic review. Med Sci Sports Exerc. 2019;51(6):1252-1261. doi:10.1249/MSS.0000000000001937.
14. Benke IN, Leitzmann MF, Behrens G, Schmid D. Physical activity in relation to risk of prostate cancer: a systematic review and meta-analysis. Ann Oncol. 2018;29(5):1154-1179. doi:10.1093/annonc/mdy073.
15. Singh F, Newton RU, Taaffe DR, Lopez P, Thavaseelan J, Brown M, et al. Prehabilitative versus rehabilitative exercise in prostate cancer patients undergoing prostatectomy. J Cancer Res Clin Oncol. 2023;149(18):16563-16573. doi:10.1007/s00432-023-05409-3.
16. Baumann FT, Reimer N, Gockeln T, Reike A, Hallek M, Ricci C, et al. Supervised pelvic floor muscle exercise is more effective than unsupervised pelvic floor muscle exercise at improving urinary incontinence in prostate cancer patients following radical prostatectomy - a systematic review and meta-analysis. Disabil Rehabil. 2022;44(19):5374-5385. doi:10.1080/09638288.2021.1937717.
17. Milios JE, Ackland TR, Green DJ. Pelvic floor muscle training in radical prostatectomy: a randomized controlled trial of the impacts on pelvic floor muscle function and urinary incontinence. BMC Urol. 2019;19(1):116. doi:10.1186/s12894-019-0546-5.
18. Houben LHP, Overkamp M, van Kraaij P, Trommelen J, van Roermund JGH, de Vries P, et al. Resistance exercise training increases muscle mass and strength in prostate cancer patients on androgen deprivation therapy. Med Sci Sports Exerc. 2023;55(4):614-624. doi:10.1249/MSS.0000000000003095.
19. Rantaniemi L, Jussila I, Siltari A, Ahtiainen JP, Hakulinen A, Harju E, et al. Is exercise during androgen deprivation therapy effective and safe? A randomized controlled trial. Scand J Med Sci Sports. 2025;35(6):e70084. doi:10.1111/sms.70084.
20. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med. 2005;352(2):154-164. doi:10.1056/NEJMoa041943.
21. Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010;28(2):340-347. doi:10.1200/JCO.2009.23.2488.
22. Lam T, Cheema B, Hayden A, Lord SR, Gurney H, Gounden S, et al. Androgen deprivation in prostate cancer: benefits of home-based resistance training. Sports Med Open. 2020;6(1):59. doi:10.1186/s40798-020-00288-1.
23. Friedenreich CM, Wang Q, Neilson HK, Kopciuk KA, McGregor SE, Courneya KS. Physical activity and survival after prostate cancer. Eur Urol. 2016;70(4):576-585. doi:10.1016/j.eururo.2015.12.032.
24. Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375-2390. doi:10.1249/MSS.0000000000002116.
25. Galvão DA, Taaffe DR, Spry N, Cormie P, Joseph D, Chambers SK, et al. Exercise preserves physical function in prostate cancer patients with bone metastases. Med Sci Sports Exerc. 2018;50(3):393-399. doi:10.1249/MSS.0000000000001454.
26. Toohey K, Hunter M, Paterson C, Mortazavi R, Singh B. Exercise adherence in men with prostate cancer undergoing androgen deprivation therapy: a systematic review and meta-analysis. Cancers (Basel). 2022;14(10):2452. doi:10.3390/cancers14102452.
27. Patel A, Schofield GM, Keogh JW. Barriers to physical activity in prostate cancer survivors. N Z Med J. 2021;134(1545):60-67.
28. Elbourne H, Soo WK, O'Reilly V, Moran A, Steer CB. Exercise as a supportive care strategy in men with prostate cancer receiving androgen deprivation therapy at a regional cancer centre: a survey of patients and clinicians. Support Care Cancer. 2022;30(2):1379-1389. doi:10.1007/s00520-021-06512-2.
29. Collado-Mateo D, Lavín-Pérez AM, Peñacoba C, Del Coso J, Leyton-Román M, Luque-Casado A, et al. Key factors associated with adherence to physical exercise in patients with chronic diseases and older adults: an umbrella review. Int J Environ Res Public Health. 2021;18(4):2023. doi:10.3390/ijerph18042023.
30. Sangameswaran S, Casanova-Perez R, Patel H, Cronkite DJ, Idris A, Rosenberg DE, et al. Improving physical activity among prostate cancer survivors through a peer-based digital walking program. AMIA Annu Symp Proc. 2024;2023:608-617.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Julia Kaczmarek, Michał Błażuk, Rafał Ejsner, Kinga Kościółek, Aleksandra Grelowska, Oliwia Dziewięcka, Wojciech Ziębka

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 20
Number of citations: 0